TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
82 hedge funds and large institutions have $704M invested in Taro Pharmaceutical Industries Ltd. in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $665M → $704M (+$38.7M)
80% less call options, than puts
Call options by funds: $308K | Put options by funds: $1.54M
Holders
82
Holding in Top 10
9
Calls
$308K
Puts
$1.54M
Top Buyers
| 1 | +$9.39M | |
| 2 | +$7.65M | |
| 3 | +$7.06M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$6.53M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$6.24M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$24.7M | |
| 3 | -$11.8M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$10.3M |
| 5 |
MCP
Moab Capital Partners
Southampton,
New York
|
-$4.57M |